These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12669118)

  • 41. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Factor XIII as a stimulator of thrombin activity].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1976; 22(4):562-6. PubMed ID: 1027244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
    Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
    Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
    Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE; Scheraga HA
    Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency.
    Kangsadalampai S; Yenchitsomanus P; Chelvanayagam G; Sawasdee N; Laosombat V; Board P
    Eur J Haematol; 2000 Oct; 65(4):279-84. PubMed ID: 11073170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary structure of human coagulation factor XIII.
    Ichinose A; Davie EW
    Adv Exp Med Biol; 1988; 231():15-27. PubMed ID: 3414431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The normal and abnormal genes of the a and b subunits in coagulation factor XIII.
    Ichinose A; Izumi T; Hashiguchi T
    Semin Thromb Hemost; 1996; 22(5):385-91. PubMed ID: 8989821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
    Enyedy EJ; Kovach IM
    J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates.
    Hosokawa K; Ohnishi T; Shima M; Nagata M; Koide T
    Biochem J; 2001 Mar; 354(Pt 2):309-13. PubMed ID: 11171108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin.
    Mikuni Y; Iwanaga S; Konishi K
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1393-403. PubMed ID: 4754717
    [No Abstract]   [Full Text] [Related]  

  • 55. An equilibrium study of metal ion binding to human plasma coagulation factor XIII.
    Lewis BA; Freyssinet JM; Holbrook JJ
    Biochem J; 1978 Feb; 169(2):397-402. PubMed ID: 629762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New general approach for determining the solution structure of a ligand bound weakly to a receptor: structure of a fibrinogen Aalpha-like peptide bound to thrombin (S195A) obtained using NOE distance constraints and an ECEPP/3 flexible docking program.
    Maurer MC; Trosset JY; Lester CC; DiBella EE; Scheraga HA
    Proteins; 1999 Jan; 34(1):29-48. PubMed ID: 10336381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide mimetics of the thrombin-bound structure of fibrinopeptide A.
    Nakanishi H; Chrusciel RA; Shen R; Bertenshaw S; Johnson ME; Rydel TJ; Tulinsky A; Kahn M
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1705-9. PubMed ID: 1542664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype.
    Schroeder V; Kohler HP
    Blood; 2003 Jan; 101(1):371-2; author reply 372. PubMed ID: 12485939
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrin--recombinant human factor XIII a-subunit association.
    Procyk R; Bishop PD; Kudryk B
    Thromb Res; 1993 Jul; 71(2):127-38. PubMed ID: 8362376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha-thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity.
    Hornyak TJ; Bishop PD; Shafer JA
    Biochemistry; 1989 Sep; 28(18):7326-32. PubMed ID: 2819071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.